56.70
Inspire Medical Systems Inc stock is traded at $56.70, with a volume of 1.09M.
It is up +1.00% in the last 24 hours and up +5.70% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$56.14
Open:
$56.05
24h Volume:
1.09M
Relative Volume:
0.97
Market Cap:
$1.63B
Revenue:
$911.98M
Net Income/Loss:
$145.42M
P/E Ratio:
11.42
EPS:
4.9642
Net Cash Flow:
$78.48M
1W Performance:
+0.69%
1M Performance:
+5.70%
6M Performance:
-21.34%
1Y Performance:
-64.09%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
56.70 | 1.63B | 911.98M | 145.42M | 78.48M | 4.9642 |
|
ABT
Abbott Laboratories
|
89.46 | 155.82B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
294.73 | 112.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
80.00 | 102.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
56.50 | 83.97B | 20.62B | 3.56B | 3.66B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
83.98 | 48.42B | 6.30B | 1.07B | 1.34B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Is It Time To Revisit Inspire Medical Systems (INSP) After A Sharp Share Price Pullback - Sahm
Vanguard reports 5.10% stake in Inspire Medical | INSP SEC FilingForm SCHEDULE 13G - Stock Titan
Why is Inspire (INSP) down 2.4% since last earnings report? - MSN
Is Inspire Medical Systems (INSP) Pricing In A Turnaround After A 66% One Year Slide? - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $3.54 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical surges after KeyBanc sees CMS adding codes for Inspire V implant - MSN
Vanguard Portfolio Management (INSP) reports 5.71% ownership of Inspire Medical Systems - Stock Titan
Sleep apnea device maker Inspire Medical speaks at BofA on May 13 - Stock Titan
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Hasbro, Inc. (HAS), Humana Inc. (HUM), Ibotta, Inc. (IBTA), and Inspire Medical Systems, Inc. (INSP) - The Daily Tribune News
Analysts estimate Inspire Medical Systems (INSP) to report a decline in earnings: What to look out for - MSN
Here's why you should add Inspire Medical stock to your portfolio now - MSN
Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Inspire Medical Systems (INSP) Projected to Post Earnings on Monday - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 28% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook - MSN
Inspire Medical Systems Stock Targets Lowered Ahead of Earnings - HarianBasis.co
Inspire jumps on major change to Medicare reimbursement - MSN
Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1 - Yahoo Finance
A Look At Inspire Medical Systems (INSP) Valuation After Recent Share Price Reset - simplywall.st
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today.Annual Report - Xã Thanh Hà
Inspire Medical Systems Inc (INSP) Stock Up 4.2% and Still Under - GuruFocus
M&T Bank Corp Takes $85.87 Million Position in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems Hits Day Low at $51.88 Amid Price Pressure - Markets Mojo
How Inspire Medical Systems Inc. (INSP) Affects Rotational Strategy Timing - Stock Traders Daily
Inspire Medical Systems (NYSE:INSP) Shares Down 8.3%Time to Sell? - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Analysis: 25% Potential Upside Beckons Investors - DirectorsTalk Interviews
Hedge funds view Inspire Medical (INSP) as one of the best small-cap healthcare stocks - MSN
Is It Time To Revisit Inspire Medical Systems (INSP) After A Sharp Share Price Pullback? - Sahm
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Director at Inspire Medical Systems (INSP) receives 307-share stock grant - Stock Titan
Inspire Medical (INSP) director gets 342-share stock fee grant - Stock Titan
Director Ellis receives 518 Inspire Medical (INSP) shares as fees - Stock Titan
Director Tansey receives 308 Inspire Medical (INSP) shares as fees - Stock Titan
Inspire Sleep Apnea Lawsuit Alleges Man Suffered Hours of Electrical Shocks From Device - AboutLawsuits.com
Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Zacks Research - MarketBeat
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $64.00 by Analysts at Truist Financial - MarketBeat
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $64 - 富途牛牛
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2025 Earnings Call Transcript - MSN
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 3 - GuruFocus
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):